Regulated information

Get easy access to all the information you need. The documentation center allows you to open, send by e-mail or download any document. Feel free to use the filters and add several documents to your basket.

Name	Date	Type
Vétoquinol markets CEFTIOCYL® and KEFLORIL® two new injectable antibiotics for livestock Lure, December 15, 2010 – In line with recent announcements, Vétoquinol is launching Ceftiocyl® and Kefloril®, two new injectable antibiotics for livestock. The products are being brought to market by the Group and its subsidiaries in both domestic and export markets.	15/12/2010	Public releases
Monthly information regarding the total number of voting rights and shares making of the share capital - November 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »	07/12/2010	Voting rights
Programme de rachat - novembre 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres	07/12/2010	Monthly communication regarding buyback programs
Vétoquinol appoints RÉGIS VIMAL DU MONTEIL Group Finance and Legal Director November 30, 2010 (Lure, France) – Vétoquinol has appointed Régis Vimal du Monteil as Group Legal and Financial Director.	30/11/2010	Public releases
Vétoquinol registers its injectable Marbocyl® 2% and Marbocyl® 10% antibiotics in Japan November 18, 2010 (Lure, France) – Vétoquinol has just obtained Marketing Authorisation (MA) from Japanese drug authorities for its Marbocyl® 2% and Marbocyl® 10% antibiotics for livestock, through collaboration with Meiji Seika Kaisha, Ltd.	18/11/2010	Public releases
Monthly information regarding the total number of voting rights and shares making of the share capital - October2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »	10/11/2010	Voting rights
Programme de rachat - octobre 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres	10/11/2010	Monthly communication regarding buyback programs
Strong Sales in the 3rd Quarter of 2010 Vétoquinol’s revenues for the third quarter of 2010 rose by 10.8%. This healthy rate of growth was attributable mainly to strong performance in the Group’s strategic regions and therapeutic segments.	19/10/2010	Public releases
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »	08/10/2010	Voting rights
Programme de rachat - septembre 2010(french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres	08/10/2010	Monthly communication regarding buyback programs